✦ LIBER ✦

Long-term effect of lamivudine treatment in patients with chronic hepatitis B: how long should we continue lamivudine therapy after HBEAG loss or seroconversion?

✍ Scribed by S.P. Hong; K.-H. Han; S.H. Ahn; Y.H. Paik; K.S. Lee; C.Y. Chon; Y.M. Moon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B surface antigen seroconversi

✍ R. Idilman; K. Cinar; G. Seven; Y. Bozkus; A. Elhan; M. Bozdayi; C. Yurdaydin; K 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

Focus: Long-term treatment with lamivudi

✍ Daniel Shouval 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 162 KB

Long-term outcome and hepatocellular car

✍ Haruhiko Kobashi; Yasuhiro Miyake; Fusao Ikeda; Tetsuya Yasunaka; Ken Nishino; A 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 681 KB

Changes in different regions of hepatiti

✍ M. Buti; R. Jardi; F. Rodriguez-Frias; A. Valdes; M. Schaper; R. Esteban; J. Gua 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

525 Long-term nucleos(t)ide therapy of c

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 251 KB

P.102 Long-term adefovir dipivoxil treat

✍ S.J. Hadziyannis; N.C. Tassopoulos; T. Chang; J. Heathcote; G. Kitis; M. Rizzett 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 138 KB